IDH and ATRX mutations, 1p19q codeletions, and TP53 mutations are early events in gliomagenesis, and the tumor behavior of lower-grade gliomas can be predicted depending on these key molecules. The gene discussed is IDH1; the disease is central nervous system cancer.